Sexually Transmitted Diseases

A study on chlamydia and gonorrhea shows testing rates have steadily gone up, but only half of MSM had been tested during 2016-2017 with less than one-third of tests being 3-site.

Julie Zuñiga, PhD, RN, shares findings from her research on self-management of the dual diagnosis of HIV and diabetes.

Rasheeta Chandler, PhD, RN, emphasizes including of black women in efforts to end the HIV epidemic and discusses an app she is developing to help women access information about sexual health.

A poster presented at ANAC2019 detailed a trauma-informed care education program for nurses providing inpatient care to people living with HIV which received a positive reception from nursing professionals.

Several key populations with heightened risk for HIV face criminalization in Botswana. The Botswana Family Welfare Association targeted efforts to improve care for these key populations.

Heather Alt, BSN, RN, ACRN, CPH, discusses research on a nurse-led model for same-day initiation of antiretroviral therapy for people newly diagnosed with HIV.

An educational research study reveals positive attitudes and a willingness to provide care among pre-licensure Bachelor of Science nursing students.

Inmates at an NJ facility have their HIV treatment needs met while incarcerated but the lack of transitional care coordination has led many individuals to fall off of the care continuum upon release.

Timothy Ray Brown is the first person to ever be cured of HIV. He discusses his decision to no longer remain anonymous and why he shares his story with the world.

As HIV treatment shifts into primary care, it is important to educate NPs on HIV care and prevention in order to maintain recent gains towards ending the HIV epidemic.

A new study examined young adults with perinatally acquired HIV living in South Florida in order to shed light on their lived experiences.

“My story is important only because it proves that HIV can be cured. And if something has happened, once in medical science, it can happen again,” Brown told Contagion®.

Shannon Weber, MSW, delivered the opening keynote at ANAC 2019 on the importance of empathy when working with people living with HIV.

People living with HIV are twice as likely as those who do not have HIV to develop cardiovascular disease, yet recent data suggest this population does not meet recommended levels of physical activity.

There is a vast unmet need for non-pharmacological treatment strategies to protect and improve cognitive function in the approximately 50% of adults living with HIV who experience HIV-associated neurocognitive disorder.

The number of STI screenings increased exponentially from 369 rectal and pharyngeal swabs performed in 2015 prior to policy implementation to 865 swabs in 2016, 1474 swabs in 2017, and 1889 swabs in 2018.

Sexually-transmitted Campylobacter clusters were genetically similar in the Seattle and Montreal regions. Campylobacter can be associated with “a bad week or 2” and even Guillain-Barre syndrome.

The Cooper Early Intervention Program Expanded Care Clinic observed that the gap in retention in care among patients with HIV was reduced from 15% to 10% over a span of 3 months.

A team of investigators from Indiana University set out to examine levels of PrEP awareness among black men in a rural midwestern city to identify barriers and facilitators to PrEP uptake and access.

Among participants in the study arm, the app resulted in significant changes, particularly in fatigue intensity and overall fatigue-related functioning

Investigators at Northeastern conducted a trial that evaluated if a video series designed for the viewer to identify with characters and “transport” themselves into the storyline lead to an increase in HIV testing.

An online survey found that people living with HIV who had lower incomes are at a higher risk for household material hardships and poorer health outcomes.

Nurses stationed in public sexual health services and specialist HIV general physician practice study sites were integral in facilitating rapid PrEP uptake.

A new review in The Lancet HIV discusses the next generation of HIV prevention, called PrEP 2.0.

The FDA has authorized marketing of the Sentosa SQ HIV Genotyping Assay, which detects HIV-1 mutations in patients undergoing or about to initiate antiviral treatment.